Healthcare
BlossomHill Therapeutics, Inc.
BLSM$22.01+9.94%
Price is delayed.
Add to watchlist
About BlossomHill Therapeutics, Inc.
BlossomHill Therapeutics is a drug development company working on cancer treatments. The company is still in the research and testing phase and has not yet brought any drugs to market. Its main focus is developing small molecule medicines, which are drugs made of relatively simple chemical structures, for cancers including lung cancer and blood cancers like leukemia. The company was founded in 2020 and is based in San Diego, California.
Loading chart...
Members only
Full research is for ConvictionStocks members
Members read the rest of this page. Where we have it for this company, that is:
- What each number means, in plain English, with the Wall Street name where the two differ.
- A plain-English summary of the company.
- How many analysts cover it, and the count behind each rating.
- Recent news, dated.
Get the free weekly market digest
The week's biggest movers, every Sunday. No spam.
Look up another company
Related Research
More Healthcare stocks to explore